These case reports underscore the importance of considering injection site modification as a first-line intervention for body aches that correlate with the injection schedule
To view a copy of this license, visit About this article Cite this article Bonifcio, V.D.B., Pereira, S.A., Serpa, J
The condition affects approximately 30 million adults in the United States, though many cases remain undiagnosed
This is due to its convenience and noninvasive administration
These same molecules were also subsequently approved for weight lossliraglutide in 2014, and semaglutide, as Wegovy, in 2021
This makes the long-term maintenance cost more manageable than the peak treatment cost, though it remains a significant ongoing expense